Capturing Physiologic Autonomic Data from Clinically Indicated Magnetic Resonance Imaging Scans in Children (CMRI)

The Fontan Procedure is a palliative surgical procedure used in pediatric patients with one functional ventricle. The procedure, a series of stepwise operations that alter cardiorespiratory physiology, separate the systemic and pulmonary circulations to create Fontan physiology, where the systemic venous blood flows passively and without ventricular thrust into the pulmonary circulation. The hallmark of the Fontan circulation is a sustained, abnormally elevated central venous pressure combined with decreased cardiac output, especially during periods of increased demands. Results of several studies in Fontan patients have shown reduced parasympathetic and sympathetic activity compared to controls. In children with congenital heart disease, a differential diagnosis of autonomic dysfunction may be part of their pathophysiology, a compensatory mechanism, a consequence of surgical procedures or a combination of these.

In children, measurement of ANS function is equally important. Children with single ventricle physiology (and other cardiac conditions) have routine surveillance and cardiac magnetic resonance (CMR) imaging to monitor for disease progression. While autonomic data is routinely collected and is available from these scans, these data are rarely, collected and analyzed; however, our group has shown feasibility. Therefore, autonomic data is usually unavailable in children. Despite the availability of agerelated normal values, the predictive power of autonomic activity is understudied in children and there are no published studies of quantification of autonomic data in this population.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Cincinnati Children's Hospital Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients presenting for clinically indicated CMR scans with planned cine sequence and use of a respiratory bellows.

Description

Inclusion Criteria:

  • Ages 0 to ≤ 30 years
  • Baseline sinus rhythm (interventricular conduction delays and bundle branch blocks allowed); and undergoing CMR scan in which sequences containing timing of aortic valve opening (cine), vector cardiogram (VCG) and respiratory bellows use will be obtained
  • Fontan physiology - only for the Fontan group. Chest wall deformity or arrhythmogenic right ventricular cardiomyopathy for the healthy control group

Exclusion Criteria:

  • Patient or family refusal;
  • Contraindication to study procedures
  • Prior participation in the study (ie, we plan to sample without replacement)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Fontan
Patients undergoing cardiac MRI for Fontan,
Patients will wear the VU-AMS monitor prior to MRI.
Healthy controls
Patients undergoing thoracic MRI for chest wall deformity.
Patients will wear the VU-AMS monitor prior to MRI.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
80% availability of respiratory sinus arrhythmia from cardiac MRI (magnetic resonance imaging)
Time Frame: Through MRI completion up to one hour
Data collected during MRI
Through MRI completion up to one hour

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare estimate of pre-ejection period (PEP)
Time Frame: Prior to MRI scan up to 10 minutes
Collection of data from VU-AMS monitor
Prior to MRI scan up to 10 minutes
Compare estimate of pre-ejection period (PEP)
Time Frame: Through MRI completion up to one hour
Collection of data from the cardiac MRI
Through MRI completion up to one hour
Describe difference in respiratory sinus arrhythmia in participants with Fontan
Time Frame: Through MRI completion up to one hour
Collection of data from the cardiac MRI
Through MRI completion up to one hour
Describe difference in respiratory sinus arrhythmia in participants with pectus
Time Frame: Through MRI completion up to one hour
Collection of data from the cardiac MRI
Through MRI completion up to one hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pornswan Ngamprasertwong, MD, Children's Hospital Medical Center, Cincinnati

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 3, 2023

Primary Completion (Actual)

November 25, 2024

Study Completion (Actual)

November 25, 2024

Study Registration Dates

First Submitted

October 19, 2023

First Submitted That Met QC Criteria

October 25, 2023

First Posted (Actual)

November 1, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 27, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Anomaly

Clinical Trials on VU-AMS device

Subscribe